ELVN peer analysis
Enliven Therapeutics (ELVN) against its competitors: price, today's move, 1-year return and market value side by side.
ELVN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -34.85% | – |
| CGEM Cullinan Therapeutics | $11.51 | 6.57% | 44.73% | – |
| EXEL Exelixis | $69.57 | 1.25% | 81.13% | $17.75B |
| INCY Incyte | $120.00 | 1.69% | 14.68% | $25.04B |
| NUVB Nuvation Bio | $4.19 | 0.00% | -13.46% | – |
| ORIC Oric | $8.82 | 3.89% | -31.06% | $968.12M |
| RLAY Relay Therapeutics | $18.88 | 11.06% | 147.52% | – |
| RVMD Revolution Medicines | $194.38 | 9.41% | 203.47% | $42.80B |
| SNDX Syndax Pharmaceuticals | $9.70 | 3.52% | -39.22% | $940.80M |
| TYRA Tyra Biosciences | $21.15 | 1.24% | 39.00% | – |
| ELVN Enliven Therapeutics | $49.75 | 11.07% | 135.14% | – |
- ELVN's peers: AVBP (ArriVent BioPharma), CGEM (Cullinan Therapeutics), EXEL (Exelixis), INCY (Incyte), NUVB (Nuvation Bio), ORIC (Oric), RLAY (Relay Therapeutics), RVMD (Revolution Medicines).
Updated 2026-11-07 11:56 UTC